# FDA Inspection 1118644 - Granules India Limited - February 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/granules-india-limited/e944d7ad-7bc6-4e13-834e-8dd487037e68
Source feed: FDA_Inspections

> FDA Inspection 1118644 for Granules India Limited on February 14, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118644
- Company Name: Granules India Limited
- Inspection Date: 2020-02-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1248503 - 2024-09-06](https://www.keypedia.com/records/fda_inspections/granules-india-limited/fafbbf18-17ed-4ac4-bd8a-6d8705e8c706)
- [FDA Inspection 1050607 - 2018-03-23](https://www.keypedia.com/records/fda_inspections/granules-india-limited/1db8ee74-e589-4a94-81f5-9692355dcaa2)
- [FDA Inspection 992723 - 2016-10-14](https://www.keypedia.com/records/fda_inspections/granules-india-limited/51f8ec49-5cc9-4bbf-8649-01781483fec3)
- [FDA Inspection 918291 - 2015-03-13](https://www.keypedia.com/records/fda_inspections/granules-india-limited/f23dcce6-2e97-4571-a280-10165728f3fe)
- [FDA Inspection 801724 - 2012-09-13](https://www.keypedia.com/records/fda_inspections/granules-india-limited/63647fb3-e1ef-4b06-9c8c-94651cf887f9)

Company: https://www.keypedia.com/companies/granules-india-limited/e2f27ea6-6e3b-4432-a874-d34393d76014

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c